Dr. Patricia M Lorusso
Claim this profileYale Cancer Center
Expert in Solid Tumors
Expert in Uterine Tumors
27 reported clinical trials
43 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
IDH positive
2Uterine Tumors
Global LeaderStage IV
Stage III
IDH positive
Affiliated Hospitals
Clinical Trials Patricia M Lorusso is currently running
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting1 award Phase 12 criteria
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
More about Patricia M Lorusso
Clinical Trial Related6 years of experience running clinical trials · Led 27 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Patricia M Lorusso has experience with
- Olaparib
- TSR-022
- Pembrolizumab
- Ceralasertib
- Entinostat
- ZEN003694
Breakdown of trials Patricia M Lorusso has run
Uterine Tumors
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patricia M Lorusso specialize in?
Patricia M Lorusso focuses on Solid Tumors and Uterine Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Patricia M Lorusso currently recruiting for clinical trials?
Yes, Patricia M Lorusso is currently recruiting for 10 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Patricia M Lorusso has studied deeply?
Yes, Patricia M Lorusso has studied treatments such as Olaparib, TSR-022, Pembrolizumab.
What is the best way to schedule an appointment with Patricia M Lorusso?
Apply for one of the trials that Patricia M Lorusso is conducting.
What is the office address of Patricia M Lorusso?
The office of Patricia M Lorusso is located at: Yale Cancer Center, New Haven, Connecticut 06510 United States. This is the address for their practice at the Yale Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.